NF-κB activation as a pathological mechanism of septic shock and inflammation

Shu Fang Liu1, Asrar B. Malik2
1Div. of Pulmonary and Critical Care Medicine, Long Island Jewish Medical Center, RM B371, New Hyde Park, NY 11040, USA.
2Pharmacology,

Tóm tắt

The pathophysiology of sepsis and septic shock involves complex cytokine and inflammatory mediator networks. NF-κB activation is a central event leading to the activation of these networks. The role of NF-κB in septic pathophysiology and the signal transduction pathways leading to NF-κB activation during sepsis have been an area of intensive investigation. NF-κB is activated by a variety of pathogens known to cause septic shock syndrome. NF-κB activity is markedly increased in every organ studied, both in animal models of septic shock and in human subjects with sepsis. Greater levels of NF-κB activity are associated with a higher rate of mortality and worse clinical outcome. NF-κB mediates the transcription of exceptional large number of genes, the products of which are known to play important roles in septic pathophysiology. Mice deficient in those NF-κB-dependent genes are resistant to the development of septic shock and to septic lethality. More importantly, blockade of NF-κB pathway corrects septic abnormalities. Inhibition of NF-κB activation restores systemic hypotension, ameliorates septic myocardial dysfunction and vascular derangement, inhibits multiple proinflammatory gene expression, diminishes intravascular coagulation, reduces tissue neutrophil influx, and prevents microvascular endothelial leakage. Inhibition of NF-κB activation prevents multiple organ injury and improves survival in rodent models of septic shock. Thus NF-κB activation plays a central role in the pathophysiology of septic shock.

Từ khóa


Tài liệu tham khảo

10.1086/367707

10.1001/archsurg.1996.01430230098017

10.1016/S0006-291X(03)00184-0

10.1074/jbc.M306621200

10.1016/S0008-6363(02)00276-6

10.1038/nature01648

10.1074/jbc.M409344200

10.1038/nm1185

10.1128/IAI.68.4.1942-1945.2000

10.1074/jbc.M211831200

10.1016/S0065-2776(08)60742-7

10.1146/annurev.immunol.14.1.649

10.1016/S0041-1345(01)02521-0

10.1016/S1097-2765(01)00314-8

10.1074/jbc.M201576200

10.1016/S0898-6568(02)00080-3

10.1074/jbc.M303076200

10.1056/NEJM200103083441001

10.1073/pnas.0501675102

10.1074/jbc.M204994200

10.1083/jcb.200211104

10.1172/JCI119648

10.1172/JCI3877

10.1038/sj.emboj.7600391

10.1016/j.it.2004.03.008

10.2741/1304

10.1074/jbc.C400442200

10.1074/jbc.M409825200

10.1016/j.cell.2004.09.027

10.1161/01.CIR.100.4.361

10.1111/j.1523-1755.2004.00463.x

Carlos TMand Harlan JM.Leukocyte-endothelial adhesion molecules.Blood84: 2068–20101,1994.

10.1152/ajpheart.00394.2001

Carrasco D, Ryseck RP, and Bravo R.Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells.Development118: 1221–1231,1993.

10.1084/jem.194.9.1231

10.1074/jbc.M313731200

10.1042/bj20020444

10.1074/jbc.M205069200

10.1096/fj.02-0668fje

Chen CC, Wang JK, and Lin SB.Antisense oligonucleotides targeting protein kinase C-alpha,beta1, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.J Immunol161: 6206–6214,1998.

10.1007/s00109-003-0469-0

10.1093/emboj/cdf660

10.1161/01.CIR.0000038706.30661.86

10.1128/MCB.24.7.3048-3056.2004

10.1038/416190a

10.1124/mol.64.6.1541

10.1182/blood-2002-09-2960

10.1038/nature01326

10.1074/jbc.M102448200

10.1189/jlb.0604338

10.1172/JCI10373

10.1073/pnas.0401124101

10.4049/jimmunol.171.4.1816

10.1523/JNEUROSCI.23-24-08586.2003

10.1074/jbc.M412837200

De la Torre A, Schroeder RA, Punzalan C, and Kuo PC.Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages.J Immunol162: 4101–4108,1999.

Demarchi F, Bertoli C, Sandy P, and Schneider C.Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.J Biol Chem78: 39583–39590,2003.

10.1016/S1359-6101(00)00009-5

10.1074/jbc.M112210200

10.1128/MCB.25.15.6533-6545.2005

10.1128/JVI.78.4.1800-1816.2004

10.1073/pnas.0404132101

10.1152/ajpcell.00167.2003

10.1073/pnas.0306734101

10.1084/jem.20030141

Espinosa L, Santos S, Ingles-Esteve J, Munoz-Canoves P, and Bigas A.p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR.J Cell Sci115: 1295–1303,2002.

10.1016/S0006-291X(02)03082-6

10.1161/hh2101.098543

10.1074/jbc.M500814200

10.1074/jbc.M206718200

10.1172/JCI17337

10.1152/ajplung.2001.281.5.L1037

10.1038/ni921

10.1001/archsurg.1993.01420230020003

10.1097/00000658-200101000-00012

10.1152/ajpcell.00010.2004

10.1074/jbc.M313435200

10.1128/MCB.23.21.7780-7793.2003

10.1074/jbc.M213115200

10.1074/jbc.M107848200

10.1073/pnas.151239498

10.1074/jbc.M500754200

10.1016/S0092-8674(02)00703-1

10.1128/MCB.24.10.4502-4512.2004

10.1016/S1286-4579(01)01408-3

10.1152/ajpheart.2001.280.4.H1464

10.1084/jem.185.6.1089

10.1074/jbc.M102559200

10.1242/dev.01702

10.1074/jbc.274.1.376

10.1074/jbc.M205737200

10.1074/jbc.M202524200

10.1152/ajpheart.2001.280.3.H962

10.1101/gad.1228704

10.1016/S0006-2952(03)00491-X

10.1152/ajpcell.00632.2004

10.1126/science.1071914

10.1161/01.RES.86.7.774

10.1073/pnas.2133048100

10.1074/jbc.M310438200

10.1074/jbc.M307971200

10.1084/jem.177.4.1205

10.1038/ni1014

10.1074/jbc.M208521200

10.1172/JCI200421696

10.1124/mol.64.6.1521

10.1002/hep.20438

10.1016/0092-8674(92)90082-N

10.1093/emboj/cdg605

10.1016/j.gene.2004.07.032

10.1172/JCI110645

10.1074/jbc.M307521200

10.1074/jbc.M208696200

10.1385/CT:5:2:183

10.1097/00024382-200210000-00015

10.1074/jbc.M110832200

10.1016/j.molcel.2004.08.008

10.1124/jpet.301.2.561

10.1146/annurev.immunol.18.1.621

10.1074/jbc.M301938200

10.1038/ni1018

10.1097/00024382-199704000-00001

10.1038/ni1159

10.1016/S0014-5793(00)02185-2

10.1074/jbc.M206421200

10.1164/ajrccm.158.6.9802100

Kurtovic Jand Segal I.Recent advances in biological therapy for inflammatory bowel disease.Trop Gastroenterol25: 9–14,2004.

10.4049/jimmunol.171.4.1750

10.1074/jbc.M104227200

10.4049/jimmunol.171.9.4886

10.1002/(SICI)1521-4141(199906)29:06<1890::AID-IMMU1890>3.0.CO;2-F

10.1038/75057

10.1038/nature03491

10.1038/nm1201-1291

10.1074/jbc.M301426200

10.1074/jbc.M407627200

10.1186/cc2816

10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1

10.1038/nri910

10.1097/00003246-200004001-00005

10.1074/jbc.M402305200

10.1074/jbc.M311267200

10.1128/MCB.25.3.1113-1123.2005

10.1161/01.CIR.100.12.1330

Liu SF, Ye XB, and Malik AB.Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs.Mol Pharmacol55: 658–667,1999.

Liu SF, Ye XB, and Malik AB.In vivo inhibition of NF-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock.J Immunol159: 3976–3983,1997.

10.1002/eji.200324687

10.1016/S0002-9440(10)64425-2

10.1152/ajpgi.00173.2003

10.1074/jbc.M302105200

10.1074/jbc.M203616200

10.1074/jbc.M308941200

10.1007/s00109-003-0440-0

10.1074/jbc.M311766200

10.1074/jbc.M301945200

10.1056/NEJMoa022139

10.1172/JCI11916

10.1074/jbc.273.27.16968

10.4049/jimmunol.164.11.5564

10.1016/j.tins.2004.11.002

10.1093/embo-reports/kvf236

10.1128/MCB.21.16.5299-5305.2001

10.1165/ajrcmb.26.6.4688

10.1161/01.CIR.0000108929.93074.0B

10.1074/jbc.M310413200

10.1165/ajrcmb.22.1.3733

10.1016/j.smim.2003.10.007

10.1074/jbc.M303654200

10.1074/jbc.M207515200

10.1074/jbc.M307759200

Natoli G, Saccani S, Bosisio D, and Marazzi I.Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time.Nat Immun6: 439–445,2005.

10.1126/science.1099962

10.1128/MCB.18.12.7336

10.1074/jbc.M202970200

10.2337/diabetes.54.1.125

10.1161/01.STR.0000120732.45951.26

10.1016/j.niox.2003.07.001

10.1074/jbc.M211051200

Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, and Mackman N.Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.Mol Cell Biol14: 3772–3781,1999.

Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, and Fujimoto J.Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.Hepatology38: 335–344,2003.

10.1016/j.ejcts.2004.09.016

10.1093/emboj/18.16.4446

10.1038/sj.onc.1203239

10.1128/MCB.24.5.1823-1835.2004

10.1038/ncb1093

10.1074/jbc.M305166200

10.1074/jbc.M304565200

Parratt JR.Nitric oxide: a key mediator in sepsis and endotoxemia?J Physiol Pharmacol48: 493–506,1997.

10.1016/S1097-2765(00)80445-1

10.1016/S0076-6879(02)59191-6

10.4049/jimmunol.170.12.6280

10.1093/emboj/18.23.6694

10.1016/S1097-2765(02)00697-4

10.1074/jbc.M306273200

10.1097/00024382-200014020-00007

10.1152/ajpheart.00854.2004

10.1161/01.CIR.0000085362.40608.DD

10.1074/jbc.M406619200

10.1152/ajpregu.00034.2002

Rahman A, Anwar KN, True AL, and Malik AB.Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.J Immunol162: 5466–5476,1999.

10.1073/pnas.0400588101

10.1172/JCI200319523

10.1038/nrm1104

10.1152/ajplung.2000.279.3.L528

10.1016/S1097-2765(03)00490-8

10.1084/jem.20040196

10.1093/infdis/172.4.1001

10.1152/ajpcell.00444.2002

Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, and Wiener-Kronish JP.IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia.J Immunol159: 2858–2866,1997.

10.1016/S1097-2765(03)00390-3

10.1016/S1074-7613(03)00237-1

10.1097/00003246-199608000-00004

10.1016/0092-8674(86)90346-6

10.4049/jimmunol.172.2.1054

10.1152/ajpcell.00296.2004

10.1016/0092-8674(95)90415-8

10.1152/ajpheart.1998.275.3.H1084

10.1016/1357-4310(95)80019-0

10.1124/mol.61.5.953

10.1177/09680519020080020301

10.1097/01.CCM.0000085186.14867.F7

10.1128/MCB.18.6.3395

Shenkar R, Yum HK, Arcaroli J, Kupfner J, and Abraham E.Interactions between CBP, NF-κB, and CREB in the lungs after hemorrhage and endotoxemia.Am J Physiol Lung Cell Mol Physiol281: L418–L426,2001.

10.1016/j.bcp.2004.04.026

10.1038/nri1629

10.1146/annurev.cb.10.110194.002201

10.1074/jbc.M304802200

10.1097/00024382-200204000-00011

10.1182/blood-2004-03-0928

10.1073/pnas.94.18.9792

10.1016/S0092-8674(03)00002-3

10.4049/jimmunol.172.9.5727

10.1038/ni823

10.1172/JCI11830

10.1074/jbc.M212389200

10.1046/j.1523-1755.2003.00781.x

10.4049/jimmunol.169.1.10

10.1046/j.1523-1755.2003.00714.x

10.1016/0092-8674(95)90506-5

10.1067/mtc.2001.115917

10.1038/nri1396

10.1128/MCB.24.3.1007-1021.2004

10.1074/jbc.M309300200

10.1084/jem.20040446

10.1096/fasebj.14.5.815

10.4049/jimmunol.174.1.426

10.1152/ajpregu.2001.281.3.R1013

10.1074/jbc.M303248200

10.1074/jbc.M306040200

10.1067/msy.1999.99058

10.1124/mol.64.4.923

10.1007/BF03256650

10.1074/jbc.M209814200

10.1016/S0014-5793(04)00157-7

10.1084/jem.180.1.95

10.3748/wjg.v10.i16.2361

10.1016/j.molimm.2003.10.006

10.1038/nature01576

10.1074/jbc.M103426200

10.1074/jbc.M106103200

10.1074/jbc.M212216200

10.1074/jbc.M205544200

10.1074/jbc.M402362200

10.1161/hh2201.099373

10.1074/jbc.C000083200

10.1164/ajrccm.162.4.9908093

10.1016/S1097-2765(02)00477-X

10.4049/jimmunol.171.12.6827

10.1152/ajpgi.00431.2002